Bremsstrahlung Imaging: A Valid Alternative For Dose Estimation In Patients Undergoing 90Y Zevalin Treatment

被引：0
|
作者：
Arrichiello, C. [1 ]
Mormile, M. [1 ]
D'Ambrosio, L. [1 ]
De Martinis, F. [1 ]
Squame, E. [1 ]
Frigeri, F. [1 ]
Arcamone, M. [1 ]
Aurilio, M. [1 ]
Aloj, L. [1 ]
Lastoria, S. [1 ]
机构：
[1] Fdn G Pascale, Ist Nazl Tumori, Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [31] Phase II study of 90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma
    Lossos, Izidore S.
    Fabregas, Jesus C.
    Koru-Sengul, Tulay
    Miao, Feng
    Goodman, Deborah
    Serafini, Aldo N.
    Hosein, Peter J.
    Stefanovic, Alexandra
    Rosenblatt, Joseph D.
    Hoffman, James E.
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1750 - 1755
  • [32] PET/CT and Bremsstrahlung Imaging After 90Y DOTANOC Therapy for Rectal Net With Liver Metastases
    Abdulrezzak, Ummuhan
    Kula, Mustafa
    Tutus, Ahmet
    Buyukkaya, Fikret
    Karaca, Halit
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (10) : 799 - 801
  • [33] Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization
    Schobert, Isabel
    Chapiro, Julius
    Nezami, Nariman
    Hamm, Charlie A.
    Gebauer, Bernhard
    Lin, MingDe
    Pollak, Jeffrey
    Saperstein, Lawrence
    Schlachter, Todd
    Savic, Lynn J.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (08) : 1066 - 1072
  • [34] Collimator and energy window optimization for 90Y bremsstrahlung SPECT imaging: A SIMIND Monte Carlo study
    Roshan, Hoda Rezaei
    Mahmoudian, Babak
    Gharepapagh, Esmaeil
    Azarm, Ahmadreza
    Islamian, Jalil Pirayesh
    APPLIED RADIATION AND ISOTOPES, 2016, 108 : 124 - 128
  • [35] Phase II study of 90y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma
    Fabregas, Jesus C.
    Hoffman, James E.
    Koru-Sengul, Tulay
    Feng, Miao
    Goodman, Deborah
    Serafini, Aldo
    Hosein, Peter J.
    Stefanovic, Alexandra
    Rosenblatt, Joseph D.
    Lossos, Izidore S.
    BLOOD, 2014, 124 (21)
  • [36] Y-90 Bremsstrahlung post therapy imaging for patients treated with Y-90 microspheres
    Hooker, C. A.
    Ruiz, D.
    Kalogianni, E.
    Chakravartty, R.
    Corcoran, B.
    Mulholland, N.
    Vivian, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S313 - S313
  • [37] Pre-therapy imaging for 90Y microsphere treatment demonstrates limited predictability for tumour absorbed dose
    Craig, A. J.
    Rojas-Fisher, B.
    Denis-Bacelar, A. M.
    Murray, I.
    Khan, N.
    Maenhout, A.
    Hossen, L.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S813 - S814
  • [38] Phase II study of Yttrium 90 (90Y) lbritumomab tiuxetan (Zevalin®) in patients with relapsed and refractory mantle cell lymphoma (MCL).
    Wang, Michael
    Oki, Yasuhiro
    Pro, Barbara
    Romaguera, Jorge Enrique
    Rodriguez, Maria Alma
    Samaniego, Felipe
    McLaughlin, Peter
    Hagemeister, Frederick
    Neelapu, Sattva
    Podoloff, Donald
    Samuels, Barry
    Loyer, Evelyne
    Zhou, Yuhong
    Younes, Anas
    BLOOD, 2006, 108 (11) : 767A - 767A
  • [39] Comparative analysis of hepatopulmonary shunt obtained from pretherapy 99mTc MAA scintigraphy and post-therapy 90Y Bremsstrahlung imaging in 90Y microsphere therapy
    Jha, Ashish Kumar A.
    Zade, Anand A.
    Rangarajan, Venkatesh
    Purandare, Nilendu
    Shah, Sneha A.
    Agrawal, Archi
    Kulkarni, Suyash S.
    Shetty, Nitin
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (05) : 486 - 490
  • [40] Absorbed dose differences in 90Y microsphere therapy between pre-treatment 99mTc-MAA and post-treatment 90Y scans
    MacLellan, Christopher
    Hobbs, Brian
    Chasen, Beth
    Murthy, Ravi
    Mahvash, Armeen
    Kappadath, Srinivas
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345